Ritalin

Phase 3Small molecule

Ritalin is one of 126 small molecule programs targeting Attention Deficit Hyperactivity Disorder. It is currently in Phase 3.

Indications

Total Trials

Active Trials

125

Competitors

Pipeline

Status by Indication[3][1]

Indication

Attention Deficit Hyperactivity DisorderActive, not recruiting

CognitionActive, not recruiting

Prostate CancerActive, not recruiting

Multiple SclerosisActive, not recruiting

Attention Deficit Hyperactivity DisorderPhase 3

Active, not recruiting

CognitionPreclinical

Active, not recruiting

Prostate CancerPhase 2

Active, not recruiting

Multiple SclerosisPhase 1

Active, not recruiting

Competition

Competitive Landscape

1399 competitors in Prostate Cancer

#DrugCompanyPhaseTrials

Ritalin

Pfizer

Phase 3

1 2

Novantrone

Pfizer

Preclinical

5 3

Mekinist

Novartis

Preclinical

3 4

Trexall

Alnylam Pharmaceuticals

Preclinical

—5

Viagra

VViatris Specialty LLC

Preclinical

1 6

Duragesic

CCephalon

Preclinical

1 7

Osmitrol

BB. Braun Medical Inc.

Preclinical

—8

Ifex

BBaxter Healthcare Corporation

Preclinical

—9

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Statin

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Attention Deficit Hyperactivity Disorder5 trials

A Comparative Effectiveness Study Evaluating OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl), and Placebo for the Treatment of Attention Deficit Hyperactivity Disorder in Children

Completed·AAlza Corporation, DE, USA·Phase 3·NCT00269789

A Multicenter Study Comparing the Efficacy and Safety of OROS Methylphenidate HCl, Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder

Completed·AAlza Corporation, DE, USA·Phase 3·NCT00269802

An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder

Completed·AAlza Corporation, DE, USA·Phase 3·NCT00269776

Show 2 more trials

Amantadine Versus Ritalin in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Unknown status·TTehran University of Medical Sciences·Phase 2·NCT01099059·40 enrolled

Influence of Stimulant Medication on Brain Processes for Decision Making in Attention Deficit Hyperactivity Disorder

Completed·MMats Fredriksen·Phase 4·NCT01831622·131 enrolled

Rehabilitation2 trials

Computer-assisted Cognitive Rehabilitation (CACR), Placebo CACR and Psycho-stimulants in the Treatment of ADHD

Completed·—·Phase 3·NCT01675804·34 enrolled

Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD

Completed·—·N/A·NCT02780102·48 enrolled

Children1 trial

Effects of Ritalin on Postural Stability of Hyper Active Children

Completed·SSoroka University Medical Center·N/A·NCT00485797·30 enrolled

Prostate Cancer1 trial

Psychostimulants for Fatigue in Prostate Cancer

Completed·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT00138138·120 enrolled

Function1 trial

Dopamine and Muscle Function in the Heat

Unknown status·—·N/A·NCT03515668·6 enrolled

6 more indications

Attention1 trial

Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD)

Completed·MMcGill University·Phase 4·NCT00483106·885 enrolled

Cognition1 trial

OT and Social Cognition in Children With ADHD: Impact of MPH

Completed·SShalvata Mental Health Center·N/A·NCT03788902·90 enrolled

Multiple Sclerosis1 trial

Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) Patients

Unknown status·SSheba Medical Center·Phase 1·NCT00220493·80 enrolled

Elderly1 trial

A Study To Evaluate The Difference In iPad-Based Cognitive Video Game (Akili Interactive's Project: EVO) Performance In Amyloid-Positive Versus Amyloid-Negative Healthy Elderly Volunteers

Completed· Pfizer logo

Pfizer··NCT02265718·97 enrolled

Treatment1 trial

Identifying Characteristic Signature of Attention Deficit / Hyperactivity Disorder (ADHD) and Ritalin Treatment

Unknown status·HHadassah Medical Organization·N/A·NCT01962181·40 enrolled

Unspecified1 trial

Motivation and Methylphenidate

Completed·IInstitut National de la Santé Et de la Recherche Médicale, France·Phase 1·NCT03190681·35 enrolled

Sources

References

[1]
ClinicalTrials.gov — 16 trial records for Ritalin. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ritalin compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ritalin. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pfizer company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: Pfizer

Ritalin

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Attention Deficit Hyperactivity Disorder5 trials

Rehabilitation2 trials

Children1 trial

Prostate Cancer1 trial

Function1 trial

Attention1 trial

Cognition1 trial

Multiple Sclerosis1 trial

Elderly1 trial

Treatment1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News